HCPCS Level II code C1875 identifies a coated or covered vascular stent supplied without a delivery system. The code covers the physical implantable device used in endovascular procedures to scaffold and seal blood vessels. Nationally, device-specific coding like C1875 matters for device tracking, hospital supply billing, and payer coverage policies for vascular interventions.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find operational benchmarks and payer coverage considerations, clinical context around device use in endovascular procedures, and common billing considerations tied to coding a stent that is billed separately from its delivery system. The publication outlines where C1875 is typically applied (inpatient and outpatient vascular procedure settings) and highlights the implications for facility billing, supply charge capture, and payer adjudication. Where specific payer policies or fee benchmarks are not provided in the source input, the text notes that those data are not available in the input. The material is intended to inform coding staff, revenue cycle managers, and clinicians involved in vascular device procurement and billing about the role and typical use of HCPCS Level II code C1875 at a national level.